✦ LIBER ✦

The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics

✍ Scribed by J.W. Lindsey; T.F. Scott; S.G. Lynch; S.S. Cofield; F. Nelson; R. Conwit; T. Gustafson; G.R. Cutter; J.S. Wolinsky; F.D. Lublin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PNP15: COST-UTILITY ANALYSIS OF THE TREA

✍ C Rubio-Terrés; F Medina; I Aristegui; G Izquierdo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PND13 A COST-EFFECTIVENESS ANALYSIS OF N

✍ R Gani; ER Samuels; S Hughes; G Giovanonni 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Evaluation of Resynchronization Therapy

✍ Bernard Thibault; François Harel; Anique Ducharme; Michel White; Nancy Frasure-S 📂 Article 📅 2011 🏛 Pulsus Group Inc 🌐 English ⚖ 822 KB

A prospective, open-label treatment tria

✍ Khan, O. A; Tselis, A. C; Kamholz, J. A; Garbern, J. Y; Lewis, R. A; Lisak, R. P 📂 Article 📅 2001 🏛 SAGE Publications 🌐 English ⚖ 95 KB

Rationale, design, and baseline characte

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Clinical outcomes after combined therapy

✍ Claus G. Roehrborn; Jack Barkin; Paul Siami; Andrea Tubaro; Timothy H. Wilson; B 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB